MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    Patients with Essential Tremor Live Longer than their Relatives

    C. Akbostanci, K. Doğanyiğit, M. Şen, E. Onat, A. Tekinay, T. Özçelik, M. Akbostanci (Snoqualmie, WA, USA)

    Objective: The objective of this study is to compare the lifespans of patients with essential tremor (ET) with their relatives. Background: Essential tremor is a movement disorder…
  • 2017 International Congress

    Ascertainment of Impaired Balance in Orthostatic Tremor Patients

    D. Bhatti, R. Thompson, x. yiwen, A. Hellman, J. Mckune, L. Schmaderer, K. Suing, C. Penke, R. Iske, B.J. Roeder, K.-C. Siu, J. Bertoni, D. Torres-Russotto (Omaha, NE, USA)

    Objective: The objective of this study was to determine if there is impairment of balance in orthostatic tremor patients which is against the current thinking…
  • 2017 International Congress

    Essential Tremor and Depression

    S. Aslam, N. Zhang, C. Adler, J. Caviness, E. Driver-Dunckley, S. Mehta, M. Sabbagh, T. Beach, H. Shill (Phoenix, AZ, USA)

    Objective: To determine if depression and neuropsychiatric symptoms are more prevalent in patients with essential tremor (ET) compared with non-ET controls and if so, to establish…
  • 2017 International Congress

    Cannabis and Parkinson’s Disease Tremor

    L. Mischley, R. Bennett, M. Sexton, G. Ricciardi, J. McNames (Kenmore, WA, USA)

    Objective: The purpose of this study was to describe the effect of Cannabis on Parkinson’s disease (PD) tremor using advanced motion detection technology and qualitative…
  • 2017 International Congress

    Head tremor in supine position does not differentiate essential tremor and cervical dystonia

    E. Ruzicka, R. Krupicka, T. Duspivova, O. Ulmanova, P. Holly, V. Cejka, J. Rusz, R. Jech (Praha, Czech Republic)

    Objective: Using objective instrumental methods, we aimed to verify the clinical utility of sitting/supine test and other clinical features to differentiate between ET and DT.…
  • 2017 International Congress

    Tremor Characteristics in Essential Tremor and Dystonic Tremor

    P. Panyakaew, H.J. Cho, M. Hallett (Bangkok, Thailand)

    Objective: To explore the characteristics of tremor in patients with ET and DT by using neurophysiologic measures. Background: Tremor features in patients with essential tremor…
  • 2017 International Congress

    Tremor in motorneuron disease: central or peripheral origin?

    A. Latorre, M. Stamelou, L. Rocchi, M. Ciocca, K. Sidle, J. Rothwell, K. Bhatia (London, United Kingdom)

    Objective: To investigate whether postural/action tremor in motorneuron disease (MND) has a central origin.  Background: MND refers to the whole spectrum of progressive degenerative diseases…
  • 2017 International Congress

    Functional lesional neurosurgery for tremor – a systematic review and meta-analysis

    S. Schreglmann, J. Krauss, J. Chang, K. Bhatia, G. Kägi (London, United Kingdom)

    Objective: To evaluate the consistency and effect size as well as the incidence of persistent side effects of lesional neurosurgical interventions using radiofrequency ablation (RF),…
  • 2017 International Congress

    A Service Evaluation of the Clinical Use of Parkinson’s KinetiGraph (PKG) Movement Recording System in the Assessment of Parkinson’s Disease Patients with Tremor

    J. Price, H. Martin, L. Ebenezer (Bronllys, United Kingdom)

    Objective: To evaluate the clinical usefulness of PKG Movement Recording System in the assessment process to aid recognition and understanding of tremor in patients with Parkinson’s disease…
  • 2017 International Congress

    TETRAS applicability and study design in randomized, placebo controlled clinical trial of Cav3 modulation for essential tremor patients.

    Y. Maricich, E. Newbold, R. Elble (Charlottesville, VA, USA)

    Objective: We will study CX-8998, a selective Cav3 antagonist with safety data in 194 patients,  in the treatment of ET. Few large controlled ET trials…
  • « Previous Page
  • 1
  • …
  • 1447
  • 1448
  • 1449
  • 1450
  • 1451
  • …
  • 1734
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley